Literature DB >> 10995512

Molecular genetic study of japanese patients with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X).

T Wada1, T Kubota, Y Fukushima, S Saitoh.   

Abstract

X-linked alpha-thalassemia/mental retardation syndrome (ATR-X) is one of the many known X-linked mental retardation syndromes. Mutations in the ATR-X gene (ATRX) that encodes a putative global transcription factor have been identified in patients with ATR-X as well as those with other forms of X-linked mental retardation syndrome. To better understand the genetic basis of ATR-X, we investigated nine patients with the ATR-X phenotype from eight independent Japanese families for mutations in ATRX. We identified seven missense mutations, including six novel mutations, all of which were located either in the N-terminal region corresponding to the putative zinc finger domain (N179S, P190L, V194I, and R246C) or in the C-terminal region corresponding to the helicase domain (V1552F, L1645S, and Y1847C). R246C was found in two independent patients. Furthermore, we investigated the origin of the mutations in seven mothers. Five mothers were found to be carriers, and two were not, indicating de novo origin of the mutations. When we compared clinical manifestations with respective mutations, we could not find apparent phenotype-genotype correlation. Therefore, the putative zinc finger domain and the helicase domains may have similar functional significance for the function of ATRX. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995512

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Inherited germline ATRX mutation in two brothers with ATR-X syndrome and osteosarcoma.

Authors:  Jianling Ji; Catherine Quindipan; David Parham; Lishuang Shen; David Ruble; Moiz Bootwalla; Dennis T Maglinte; Xiaowu Gai; Sulagna C Saitta; Jaclyn A Biegel; Leo Mascarenhas
Journal:  Am J Med Genet A       Date:  2017-03-28       Impact factor: 2.802

2.  Deletion of the Chd6 exon 12 affects motor coordination.

Authors:  Melissa J Lathrop; Lisa Chakrabarti; Jeremiah Eng; C Harker Rhodes; Thomas Lutz; Amelia Nieto; H Denny Liggitt; Sandra Warner; Jennifer Fields; Reinhard Stöger; Steven Fiering
Journal:  Mamm Genome       Date:  2010-01-29       Impact factor: 2.957

3.  Neuroradiologic features in X-linked α-thalassemia/mental retardation syndrome.

Authors:  T Wada; H Ban; M Matsufuji; N Okamoto; K Enomoto; K Kurosawa; N Aida
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-16       Impact factor: 3.825

4.  Syndromic disorder of sex development due to a novel hemizygous mutation in the carboxyl-terminal domain of ATRX.

Authors:  Masaki Takagi; Hiroko Yagi; Ryuji Fukuzawa; Satoshi Narumi; Tomonobu Hasegawa
Journal:  Hum Genome Var       Date:  2017-04-13

5.  Identification of a Hemizygous Novel Splicing Variant in ATRX Gene: A Case Report and Literature Review.

Authors:  Yan Cong; Jie Wu; Hao Wang; Ke Wu; Cui Huang; Xuejian Yang
Journal:  Front Pediatr       Date:  2022-04-04       Impact factor: 3.418

6.  The ATRX splicing variant c.21-1G>A is asymptomatic.

Authors:  Karin Kojima; Takahito Wada; Hiroko Shimbo; Takahiro Ikeda; Eriko F Jimbo; Hirotomo Saitsu; Naomichi Matsumoto; Takanori Yamagata
Journal:  Hum Genome Var       Date:  2022-09-14

7.  X-linked mental retardation-hypotonic facies syndrome: Exome sequencing identifies novel clinical characteristics associated with c.5182G>C mutation in the ATRX gene.

Authors:  Fatemeh Shakarami; Mehdi Jahani; Zahra Nouri; Mohammad Amin Tabatabaiefar
Journal:  Mol Genet Genomic Med       Date:  2022-08-13       Impact factor: 2.473

8.  Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.

Authors:  Suzy M Scholl; Jonas Beal; Leanne de Koning; Elodie Girard; Marina Popovic; Anne de la Rochefordière; Fabrice Lecuru; Virginie Fourchotte; Charlotte Ngo; Anne Floquet; Els Mjj Berns; Gemma Kenter; Pierre Gestraud; Heiko von der Leyen; Charlotte Lecerf; Vincent Puard; Sergio Roman Roman; Aurelien Latouche; Attila Kereszt; Balazs Balint; Roman Rouzier; Maud Kamal
Journal:  EBioMedicine       Date:  2020-10-20       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.